Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
暂无分享,去创建一个
A. Nagler | E. Shpall | E. Fibach | M. Austin | A. Hasson | J. Mandel | T. Peled | R. N. Goudsmid | C. Landor | N. Hasson | D. Harati | Nira Hasson | Dorit Harati
[1] A. Nagler,et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. , 2004, Experimental hematology.
[2] Pingfu Fu,et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. , 2003, Blood.
[3] J. Wingard,et al. Human cord blood long-term engrafting cells are CD34+ CD38− , 2003, Leukemia.
[4] M. Miñana,et al. CD34+CD38– is a good predictive marker of cloning ability and expansion potential of CD34+ cord blood cells , 2003, Transfusion.
[5] I. Lewis,et al. Clinical and experimental uses of umbilical cord blood , 2002, Internal medicine journal.
[6] Chan Zeng,et al. Transplantation of ex vivo expanded cord blood. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] J. Wagner,et al. Umbilical cord blood transplantation: current state of the art , 2002, Current opinion in oncology.
[8] E. Fibach,et al. Cellular copper content modulates differentiation and self‐renewal in cultures of cord blood‐derived CD34+ cells , 2002, British journal of haematology.
[9] J Wagner,et al. Current status of cord blood banking and transplantation in the United States and Europe. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] R. Spizzo,et al. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use. , 2001, Blood cells, molecules & diseases.
[11] J. Wagner,et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.
[12] P H Hénon,et al. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment. , 2001, Journal of biological regulators and homeostatic agents.
[13] W. Piacibello,et al. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model. , 2001, Journal of biological regulators and homeostatic agents.
[14] W. Piacibello,et al. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells. , 2000, Journal of hematotherapy & stem cell research.
[15] I McNiece,et al. Increased expansion and differentiation of cord blood products using a two-step expansion culture. , 2000, Experimental hematology.
[16] V. Pistoia,et al. Flow cytometric and functional characterization of AC133+ cells from human umbilical cord blood , 2000, British journal of haematology.
[17] S. Dzik. CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devicesMcNiece IK, Stoney GB, Kern BP, et al. J Hematother 7:457–461, 1998 , 1999 .
[18] E. Shpall,et al. Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. , 1999, Hematology and cell therapy.
[19] Ph,et al. Primordial role of CD34+38− cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation , 1998, British journal of haematology.
[20] B. Lord,et al. CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell Progenitors , 1998, Stem cells.
[21] I. Mcniece,et al. CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devices. , 1998, Journal of hematotherapy.
[22] M. Koller,et al. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system , 1998, Bone Marrow Transplantation.
[23] J. Kearney,et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.
[24] J. Kurtzberg,et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.
[25] J. Adamson,et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Gaddy,et al. Allogeneic responses of human umbilical cord blood. , 1994, Blood cells.
[27] J. Wagner,et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. , 1992, Proceedings of the National Academy of Sciences of the United States of America.